$Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study$

Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study

10.1080/10428194.2017.1376743

Saved in:

Bibliographic Details
Main Authors:	Hartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, Ruben Niesvizky, Wee Joo Chng, Douglas Joshua, Katja Weisel, Andrew Spencer, Robert Orlowski, Shibao Feng, Karim Iskander, Meletios A. Dimopoulos
Other Authors:	MEDICINE
Format:	Others
Published:	Taylor & Francis 2018
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/143070
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup
by: Heinz Ludwig, et al.
Published: (2018)

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
by: Chng, W-J, et al.
Published: (2022)

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
by: Moreau, P, et al.
Published: (2022)

A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
by: Chen, Yunxin, et al.
Published: (2021)

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
by: Goldschmidt, Hartmut, et al.
Published: (2022)

The Performance Impact of Experience in Creative Software Endeavors
by: FAN, Terence Ping Ching, et al.
Published: (2011)

Thrombotic microangiopathy during carfilzomib use: case series in Singapore
by: Chen, Y, et al.
Published: (2020)

Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas
by: Jeitany, Maya, et al.
Published: (2022)

Charitable organizations in Singapore: From clan based to state facilitated endeavors
by: TANG, Hang Wu
Published: (2022)

IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR
by: GRACE NGAN JIE YIN
Published: (2018)

Influence of Firm?s Recovery Endeavors upon Privacy Breach on Online Customer Behavior
by: Ben Choi, et al.
Published: (2018)

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
by: San-Miguel, J, et al.
Published: (2020)

CLOUD COMMERCE - A DESIGN SCIENCE ENDEAVOR TOWARDS NEXT GENERATION ELECTRONIC COMMERCE
by: TAN WEE KEK (CHEN WEIKE)
Published: (2013)

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
by: Tadeusz Robak, et al.
Published: (2018)

Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis.
by: Kaur, Parveen, et al.
Published: (2020)

An intravascular ultrasound study of cypher, taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden
by: Lee, C.-H., et al.
Published: (2011)

An intravascular ultrasound study of cypher, taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden
by: Lee, Chi-Hang, et al.
Published: (2016)

Bortezomib-encapsulated dual responsive copolymeric nanoparticles for gallbladder cancer targeted therapy
by: Chen, Mingyu, et al.
Published: (2023)

Dexamethasone in Cerebral Malaria
by: Anthony Hall, et al.
Published: (2018)

Subcutaneous phycomycosis mimics elephantiasis.
by: M. Riganti, et al.
Published: (2018)

Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
by: Hawley, T.S., et al.
Published: (2014)

Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis
by: Manusirivithaya S., et al.
Published: (2014)

Dexamethasone deleterious in cerebral malaria
by: D. A. Warrell, et al.
Published: (2018)

Is dexamethasone deleterious in cerebral malaria?
by: D. A. Warrell, et al.
Published: (2018)

Automated segmentation of visceral, deep subcutaneous, and superficial subcutaneous adipose tissue volumes in MRI of neonates and young children
by: Kway, Yeshe Manuel, et al.
Published: (2023)

Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma)
by: Koh, M.J.-A., et al.
Published: (2016)

Automated segmentation of visceral, deep subcutaneous, and superficial subcutaneous adipose tissue volumes in MRI of neonates and young children
by: Kway, YM, et al.
Published: (2022)

Subcutaneous phaeohyphomycosis: A rare case
by: Zahruddin Ahmad, -, et al.
Published: (2019)

Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence
by: Abid, Muhammad Bilal, et al.
Published: (2022)

Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria
by: Moreira W., et al.
Published: (2018)

Subcutaneous recombinant human erythropoietin in patients on CAPD.
by: Lye, W.C., et al.
Published: (2016)

Melatonin attenuates dexamethasone-induced spatial memory impairment and dexamethasone-induced reduction of synaptic protein expressions in the mouse brain
by: Walaiporn Tongjaroenbuangam, et al.
Published: (2018)

Formononetin regulates multiple oncogenic signaling cascades and enhances sensitivity to bortezomib in a multiple myeloma mouse model
by: Kim, C., et al.
Published: (2021)

Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma
by: Shanmugam, M.K, et al.
Published: (2020)

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitors
by: Franke, N.E, et al.
Published: (2020)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
by: Yang, M.H., et al.
Published: (2021)

Randomized, Controlled Trial of Dexamethasone Versus Dexamethasone Plus Hydrocortisone as Prophylaxis for Hypersensitivity Reactions Due to Paclitaxel Treatment for Gynecologic Cancer
by: Dhammapoj Jeerakornpassawat, et al.
Published: (2018)

Randomized, controlled trial of dexamethasone versus dexamethasone plus hydrocortisone as prophylaxis for hypersensitivity reactions due to paclitaxel treatment for gynecologic cancer
by: Dhammapoj Jeerakornpassawat, et al.
Published: (2018)

Effects of dexamethasone on the epiplexus cells in postnatal rats
by: Kaur, C., et al.
Published: (2012)

Dexamethasone receptors and their distribution in the brain of the red tilapia
by: Chen, K.M., et al.
Published: (2014)